Perakizumab

Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis.[1] It binds to IL17A and acts as an immunomodulator.[2]

Perakizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetIL17A
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6454H9964N1718O2030S44
Molar mass145515.34 g·mol−1

This drug was developed by Genentech/Roche.

References



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.